Pharmaceutical composition for preventing transition to surgical therapy for benign prostatic hyperplasia

摘要

Provide drugs that are useful for preventing the transition to surgical treatment for benign prostatic hyperplasia. The present invention relates to a pharmaceutical composition for preventing transition to surgical treatment of benign prostatic hyperplasia characterized by containing an indoline derivative represented by the following general formula (I) or a pharmacologically acceptable salt thereof: (In the formula, R is a substituted aliphatic acyl group, a hydroxyalkyl group, an aliphatic acyloxyalkyl group, a substituted lower alkyl group, a substituted aromatic acyl group, a furoyl group, a pyridylcarbonyl group, etc., and R1 is a cyano group or A carbamoyl group, and R2 represents a substitutable lower alkyl group. [Chemical 1]